Efficacy and safety of bevacizumab in the treatment of adult gliomas: a systematic review and meta-analysis
Objective To assess the efficacy and safety of bevacizumab (BEV) in patients with glioma.Design Systematic review and meta-analysis.Participants Adults aged 18 years and above, whose histology was confirmed to be malignant glioma.Primary and secondary outcome measures The main indicators included pr...
Saved in:
| Main Authors: | Kai Wang, Jianxin Guo, Tianze Sun, Tianze Wang, Zhuojun Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/12/e048975.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of combining re-irradiation with bevacizumab compared to bevacizumab alone in the management of recurrent high-grade gliomas: a meta-analysis and systematic review
by: Ali Hammed, et al.
Published: (2025-06-01) -
Efficacy and safety analyses of bevacizumab in neoadjuvant chemotherapy for ovarian cancer: a systematic review and meta-analysis
by: Yijun Wang, et al.
Published: (2025-05-01) -
Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials.
by: Ping Fang, et al.
Published: (2012-01-01) -
Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective study
by: Bai Xuexue, et al.
Published: (2025-08-01) -
Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcer
by: Jungić Saša, et al.
Published: (2017-01-01)